France’s Sanofi to buy U.S. biopharma group Blueprint for up to $9.5-billion

theglobeandmail.com/business/article-sanofi-blueprint-medicines-deal-pharma-clone

France’s Sanofi SNY-Q has agreed to buy U.S.-based Blueprint Medicines Corporation BPMC-Q for up to US$9.5-billion to boost its position in rare immunology diseases, in the biggest deal struck by a European health care company so far this year, according to LSEG data.
Blueprint is a…

This story appeared on theglobeandmail.com, 2025-06-02 10:54:19.
The Entire Business World on a Single Page. Free to Use →